USP22 and breast cancer: Despite the limitation in the sample size of our study we were able to identify two genome-wide significant signals associated with overall BC (rs899342 in the USP22 gene on chromosome 17 and risk allele rs7181788 on chromosome 15), and several comparably significant signals in our analysis of BC estrogen receptor subtypes.